EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

PINK1 deficiency permits the development of Lewy body dementia with coexisting Aβ pathology

PINK1-Mangel erlaubt die Entwicklung einer Lewy-Körper-Demenz mit gleichzeitiger Aβ-Pathologie

Tong-Yao Gao, Xu-Zheng Wang, Yu-Han Xie, Tong Wang, Yun-Bi Lu, Lu-Long Huang, Cong Chen, Ming Zhang, Xin Ma, Ya-Ling Chen, Fu-Xiang Liang, Zhi-Ling Lou und 7 weitere

Alzheimer's & Dementia · 2025-09 · 21 (9)

DOI: 10.1002/alz.70730 ↗

Auf einen Blick

In Mausmodellen und Humanhirnen war PINK1 mit Lewy- und Aβ-Pathologie verknüpft. PINK1 phosphorylierte α-Synuclein an Thr44 und hemmte so Aβ-induzierte Aggregation.

Fragestellung

Welche Rolle spielt PINK1 bei der Entwicklung von Lewy-Pathologie bei Demenz mit Lewy-Körpern und gleichzeitiger Aβ-Pathologie?

Methode

Pink1-Knockout- und APP/PS1-Mäuse wurden gekreuzt; anschließend wurden Verhaltens- und Pathologiephänotypen sowie biochemische und biophysikalische Eigenschaften der PINK1-Phosphorylierung von α-Syn untersucht.

Ergebnisse

APP/PS1::pink1-/- Mäuse entwickelten spontan Lewy-Pathologie bei endogenen α-Syn-Spiegeln. In Humanhirnen korrelierten pT44-α-Syn-Spiegel mit PINK1-Expression und -Aktivität.

Schlussfolgerung der Autor:innen

PINK1-Mangel fördert zusammen mit Aβ die Lewy-Pathologie durch den Verlust einer schützenden α-Syn-Phosphorylierung. Das Modell bildet zentrale Merkmale der DLB ohne α-Syn-Überexpression ab.

Kernaussagen

  • PINK1-Mangel war bei DLB-Hirnen mit Aβ-Ko-Pathologie beschrieben
  • PINK1 phosphorylierte α-Syn an Thr44
  • Das Mausmodell zeigte spontane Lewy-Pathologie bei endogenem α-Syn

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 24.09.2025. Verfasst von Tong-Yao Gao und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Lewy Body Disease, alpha-Synuclein, Amyloid beta-Peptides, Protein Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Science and Technology Innovation 2030-Major Project.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Dementia with Lewy bodies (DLB), a prevalent neurodegenerative dementia, involves α‐synuclein (α‐syn) aggregates and frequent amyloid beta (Aβ) co‐pathology, but mechanistic drivers remain unclear. METHODS We crossed pink1 knockout with APP/PS1 mice, and assessed behavioral and pathological phenotypes of the resulting animals. We also performed biochemical and biophysical characterizations of PTEN‐induced kinase 1 (PINK1) phosphorylation of α‐syn. RESULTS DLB brains show PINK1 deficiency alongside α‐syn and Aβ co‐pathology. Mirroring human DLB patients, APP/PS1::pink1‐/‐ mice spontaneously develop Lewy pathology at endogenous α‐syn levels, affecting both central and peripheral nervous systems with heterogeneous phenotypes. Mechanistically, PINK1 phosphorylates α‐syn at Thr44, suppressing Aβ‐induced α‐syn aggregation. Moreover, pT44‐α‐syn levels are correlated with PINK1 expression and activity in human brains. DISCUSSION PINK1 deficiency synergizes with Aβ to promote Lewy pathology via loss of protective α‐syn phosphorylation. The APP/PS1::pink1‐/‐ model recapitulates key DLB features without α‐syn overexpression, offering a valuable tool for future mechanistic and therapeutic studies. Highlights PTEN‐induced kinase 1 (PINK1) deficiency, either through reduced expression or impaired activity, is found in human dementia with Lewy bodies (DLB) patients with amyloid beta (Aβ) co‐pathology. PINK1 specifically phosphorylates α‐synuclein at Thr44, inhibiting Aβ‐induced aggregation and preventing the development of Lewy pathology. The APP/PS1::pink1‐/‐ mouse model recapitulates key features of human DLB, exhibiting widespread Lewy pathology and heterogeneous phenotypes. PINK1 alterations emerge as a novel genetic risk factor for DLB, opening new avenues for diagnosis and therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lewy Body Diseasealpha-SynucleinAmyloid beta-PeptidesProtein KinasesAnimalsMiceHumansPhosphorylationMice, KnockoutDisease Models, AnimalBrainMice, TransgenicLewy BodiesMalePTEN-Induced Putative Kinase

Stichwörter der Autor:innen

APP/PS1 mouseAlzheimer's diseaseLewy bodyLewy neuritePTEN‐induced kinase 1Parkinson's diseaseamyloid betadementia with Lewy bodiesphosphorylationα‐synuclein

Substanzen

alpha-SynucleinAmyloid beta-PeptidesProtein KinasesPTEN-Induced Putative Kinase

Autor:innen und Institutionen

  • Department of Pharmacology, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhejiang Key Laboratory of Drug Prevention and Control Technology, The Department of Criminal Science and Technology, Zhejiang Police College, Hangzhou, China.
  • Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, & Center for Quantitative Biology, PKU-THU Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Pe…
  • Beijing Dementia Key Lab, Peking University Institute of Mental Health (Sixth Hospital), National Clinical Research Center for Mental Disorders, NHC Key Laboratory of Mental Health, Peking University, Beijing, China.
  • Department of Thoracic Surgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Human Anatomy, Histology and Embryology, System Medicine Research Center, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Hua-Li Wang, Chun Tang, Wei-Ping Zhang

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Science and Technology Innovation 2030-Major Project
  • Zhejiang Provincial Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Gao, T. Y., Wang, X. Z., Xie, Y. H., Wang, T., Lu, Y. B., Huang, L. L., Chen, C., Zhang, M., Ma, X., Chen, Y. L., Liang, F. X., Lou, Z. L., Li, J. S., Yu, Y. F., Wu, J. B., Ma, X. R., Wang, H. L., Tang, C., & Zhang, W. P. (2025). PINK1 deficiency permits the development of Lewy body dementia with coexisting Aβ pathology. Alzheimer's & Dementia, 21(9). https://doi.org/10.1002/alz.70730

Vancouver

Gao TY, Wang XZ, Xie YH, Wang T, Lu YB, Huang LL, et al. PINK1 deficiency permits the development of Lewy body dementia with coexisting Aβ pathology. Alzheimer's & Dementia. 2025;21(9). doi:10.1002/alz.70730

BibTeX
@article{Gao2025,
  author = {Gao, Tong-Yao and Wang, Xu-Zheng and Xie, Yu-Han and Wang, Tong and Lu, Yun-Bi and Huang, Lu-Long and Chen, Cong and Zhang, Ming and Ma, Xin and Chen, Ya-Ling and Liang, Fu-Xiang and Lou, Zhi-Ling and Li, Jin-Sheng and Yu, Yi-Fan and Wu, Jian-Bin and Ma, Xiao-Ru and Wang, Hua-Li and Tang, Chun and Zhang, Wei-Ping},
  title = {PINK1 deficiency permits the development of Lewy body dementia with coexisting Aβ pathology},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {9},
  doi = {10.1002/alz.70730}
}
Kostenlos starten →